Document is current
Any future updates will be listed below
-
Authors
Boeke, Simon
Habrich, Jonas
Kübler, Sarah
Boldt, Jessica
Schick, Fritz
Nikolaou, Konstantin
Kübler, Jens
Gani, Cihan
Niyazi, Maximilian
Zips, Daniel
Thorwarth, Daniela
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (PAK 997/1)
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 2 October 2024
Accepted: 17 January 2025
First Online: 29 January 2025
Declarations
:
: The trial was approved by the local ethical committee (no. 659/2017BO1, NCT04172753) and all patients gave their written informant consent.
: Approval for publication of patient images was included in all patients’ written informant consent.
: The Department of Radiation Oncology Tübingen receives financial and technical support by Elekta, Philips, Dr. Sennewald Medizintechnik, Kaiku Health, TheraPanacea, PTW Freiburg, ITV and Brainlab in the context of research cooperations. The Department of Diagnostic and Interventional Radiology, University of Tübingen reports institutional collaborations, consultation and grants supported Siemens Healthineers, Erlangen, Germany and Bayer Healthcare, Leverkusen, Germany outside this study.
